Aids in the management of polycystic ovarian syndrome (PCOS) by helping to restore normal ovarian function
Aids in the management of PCOS’s hormonal and metabolic conditions by promoting healthy glucose metabolism
Aids in the management of PCOS by reducing oxidative stresses
Helps to restore ovulation and oocyte quality and to normalize menstrual cycle irregularities
Helps to reduce serum testosterone in women with PCOS
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders, affecting up to 20% of women of reproductive age.1PCOS is associated with elevated male sex hormones, impaired insulin sensitivity and reproductive dysfunction, including menstrual irregularity and infertility.1Myo-inositol helps restore the activities of ovaries in PCOS patients through its role as a precursor to inositol 1,4,5-triphosphate (InsP3), which regulates menstrual cycle hormones and oocyte maturation.3,4Myo-inositol also promotes the production of inositolphosphoglycans (IPG), which activate enzymes involved in glucose metabolism.3In a clinical trial involving 42 women with PCOS, participants were randomized to consume 400 mcg of folic acid alone or in combination with 4 g of myo-inositol daily for six to eight weeks.5When compared to the placebo folic acid group, women in the myo-inositol group experienced more cycles of ovulation (69.5% ovulated in the myo-inositol group compared with 21% in the placebo group), lower testosterone levels, and improved insulin sensitivity.5
